Last reviewed · How we verify

NCT03179189

Investigation of The Prevalence of Sepsis in Adults in Multicenter Intensive Care Unıts in Turkey

Status unknown Last updated 29 September 2017
What this trial tests

trial in Sepsis in 1,000 participants. Status unknown.

Timeline
1 October 2017
Primary endpoint
1 November 2017
1 March 2018

Quick facts

Lead sponsorIzmir Ataturk Training and Research Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 October 2017
Primary completion1 November 2017
Estimated completion1 March 2018
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Izmir Ataturk Training and Research Hospital

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The pathophysiology and treatment of sepsis disease are still not fully known. International guides often refer to the studies done in the developed countries and suggest some treatments. The infrastructure of the developing countries is quite different. For this reason, it is not exactly scientific how much these proposals are reflected in patient treatment. In our study, We will try to reveal the treatment of sepsis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Izmir Ataturk Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03179189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing